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Abstract
Background: This study aimed to investigate the reliability and validity of the Chinese version of the Patient Health
Questionnaire (PHQ-15) in a tertiary hospital.
Methods: Using a cross-sectional study design, the Chinese version of the PHQ-15 was administered to a total of
1329 inpatients. To examine the discriminant validity of this questionnaire, we investigated the correlation of the
PHQ-15 score with sociodemographic data and the PHQ-9 and GAD-7 scale scores. Exploratory factor analysis was
performed to assess the internal consistency of the PHQ-15. To evaluate the consistency of this questionnaire with
item response theory (IRT), IRT analysis was performed.
Results: The Chinese version of the PHQ-15 showed good reliability (Cronbach’s alpha = 0.83). The correlations of
the PHQ-15 scores with the PHQ-9 depression scale scores (r = 0.565) and the GAD-7 anxiety scale scores (r = 0.512)
were moderate; these results suggested that the PHQ-15 had discriminant validity. We identified three factors, referred
to as “cardiopulmonary,” “gastrointestinal,” and “pain/neurological,” which explained 56 % of the total variance.
A second-order factor analysis including these three factors produced an acceptable model. Several items (4, 8
and 11) displayed extreme floor effects. Additionally, item 4 displayed a very small variance of 0.35 and showed very small
differences in its thresholds based on IRT analysis.
Conclusions: The PHQ-15 scale had good reliability and high validity to detect patients with high somatic symptom
severity in a Chinese tertiary hospital. Several of the current findings were consistent with previous research on the
PHQ-15 in Western countries and in China. To improve the diagnostic quality of this questionnaire, items 4, 8 and 11
can be omitted.
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Background
Patients with multiple distressing somatic symptoms are
prevalent in primary, secondary and tertiary care settings
[1–4]. The Patient Health Questionnaire (PHQ)-15 [5] is
an economical, self-administered instrument that has
been used as a screening tool in several studies. More-
over, the PHQ-15 has been suggested by the DSM-5
Workgroup on Somatic Symptom Disorders (SSD) to
serve as a measure of somatic symptom severity for the
classification of SSD [6, 7].
The PHQ-15 has been developed from its precursors,
the “Primary Care Evaluation of Mental Disorders”
(PRIME-MD) [8] and the “PRIME-MD Patient Health
Questionnaire” (PRIME-MD PHQ) [9]. Previous studies
[5, 10–12] suggest that individual somatic symptoms fre-
quently cluster into 4 groups: cardiopulmonary, gastro-
intestinal, pain, and general.
Among 40 self-reported somatic symptom scales inves-
tigated in a review, the PHQ-15 and the 12-item Symptom
Checklist–90 somatization scale [13] were identified as
the most appropriate measures for large-scale studies be-
cause of their well-established psychometric properties,
relevance to symptoms, brevity, and availability in multiple
languages [11].* Correspondence: kurt.fritzsche@uniklinik-freiburg.de2Department of Psychosomatic Medicine and Psychotherapy, University
Medical Centre Freiburg, Hauptstr. 8, D-79104 Freiburg, Germany
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The PHQ-15 in Hong Kong and Mainland China
Historically, there has been a popular belief that Asians
manifest a lower prevalence of mood and anxiety disor-
ders than their Western counterparts because they are
more prone to experiencing and manifesting distress via
somatic pathways [14–16]. Among Chinese patients re-
ceiving psychiatric services, somatic symptoms such as
pain, insomnia and fatigue have been associated with de-
pressive and anxiety disorders [17].
The validity and reliability of the Chinese version of
the PHQ-15 [18] were examined in the general popula-
tion of Hong Kong. The Hong Kong version of the PHQ-
15 exhibited satisfactory internal consistency (Cronbach’s
alpha = 0.79) and stable 1-month test-retest reliability.
Somatic symptom severity positively associated with func-
tional impairment and health service use.
In mainland China, the validity and reliability of the
PHQ-15 were tested in the outpatient clinics of general
hospitals in Shanghai [19]. Cronbach’s alpha was 0.73,
and the test-retest reliability coefficient was 0.75. There
were moderate positive correlations between the PHQ-
15 score and anxiety and depression values.
No PHQ-15 data are available for tertiary hospital in-
patients in China, and no item response theory (IRT)
analyses have been performed. IRT is a probabilistic
test theory that represents a strong paradigm for the
analysis of tests or questionnaires. Compared to the “sim-
pler” classical test theory, IRT does not assume that each
item is equally difficult.
Furthermore, we found several inconsistencies in
translation among the English, Hong Kong and Shanghai
versions of the PHQ-15 (see Methods section).
The objective of the present study was to assess the
validity of the Chinese version of the PHQ-15 for the de-
tection of distressing somatic symptoms in a sample of
inpatients at a tertiary hospital.
We aimed to answer the following research questions:
1. What somatic symptoms are reported most often by
patients?
2. What is the internal consistency and discriminant
validity of the Chinese PHQ-15?
3. Is the PHQ-15 consistent with IRT?
Methods
Study design
We conducted an observational cross-sectional survey.
The study was initiated under normal clinical conditions
on a random day in October 2013.
Participants in this study were inpatients recruited from
10 departments (oncology, cardiology, respiratory medicine,
rehabilitation, geriatrics and gerontology, general practice,
pain management, thyroid and breast surgery, rheumatol-
ogy, and hepatic surgery) of the West China Hospital of
Sichuan University. The West China Hospital of Sichuan
University is a “3 A hospital,” indicating that it meets the
highest standards in China. The West China Hospital pro-
vides primary, secondary and tertiary care and has a full
complement of services, including the departments men-
tioned above.
All inpatients of these departments were considered to
be potential participants in our study. The following inclu-
sion criteria were used: (1) treatment as an inpatient in the
selected wards; (2) sufficient language skills to understand
the questionnaires; and (3) informed consent to participate
in the research. Exclusion criteria were (1) discharge from
the hospital on the day of survey completion and (2) in-
ability to independently complete the self-reported ques-
tionnaire due to serious physical debilitation or mental
status. The investigators were well trained medical doctors,
nurses or medical students. A pilot study was performed
in advance to confirm the feasibility of the study, e.g., that
the patients would agree to participate and would under-
stand the questionnaires. The investigators collected the
questionnaires from the patients.
The validation of the PHQ-15 is a component of a lar-
ger project investigating the prevalence and recognition
of inpatients with emotional distress and their treatment
needs at a general hospital.
Assessment instruments
PHQ-15
The PHQ-15 is a self-administered somatic symptoms
subscale derived from the full PHQ [5.9]. The PHQ-15 in-
cludes 15 prevalent somatic symptoms or symptom clus-
ters that represent over 90 % of the symptoms observed in
primary care (exclusive of self-limited upper respiratory
symptoms such as cough, nasal symptoms, sore throat,
and ear ache) [5]. The patients were asked to rate the se-
verity of their symptoms during the previous 4 weeks on a
3-point scale as either 0 (“not bothered at all”), 1 (“both-
ered a little”) or 2 (“bothered a lot”). Two items consisted
of questions regarding “feeling tired and having little en-
ergy” and “trouble sleeping”; these items are in the depres-
sion module of the PHQ-15.
The classification of somatic symptom severity included
minimal (0–4), mild (5–9), moderate (10–14) and severe
(15–30). The total symptom severity score ranged from 0
to 30.
The reliability of the PHQ-15 was initially supported by
the results of one study of 6000 patients from general in-
ternal medicine and family practice clinics in Phoenix [5].
In that study, the PHQ-15 demonstrated good internal
consistency (Cronbach’s alpha = 0.80) and was related to
criterion indices or physical dysfunction, self-reported dis-
ability days, clinic visits, and the amount of difficulty that
the patients attributed to their symptoms. Furthermore,
linear regressions were performed to examine the ability
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of the PHQ-15, along with other variables, such as depres-
sion scores and medical comorbidities, to independ-
ently predict clinical outcomes (e.g., bodily pain and
physical functioning).
To determine prevalence rates, a cut-off score of ≥ 10
was used because the range of 10 to 30 reflects moderate
to high somatic symptom severity. The selection of this
cut-off score was based on previous studies [20, 21].
Each item is measured using a ranking scale; therefore,
one open question is whether the sum of these data can
be interpreted as metric data. Additionally, the merits of a
3-point scale compared with a 2-point scale are discussed.
The PHQ-15 has been translated into other languages
and has been examined in samples from many countries,
e.g., Saudi Arabia, Germany, Spain, Belgium, Korea, and
the Netherlands. This evidence offers the potential for
comparisons between ethnic groups.
Translation of the PHQ-15
This study is part of the Sino-German research cooper-
ation, which was started in 2010. Workshops and a multi-
center study on illness perception and illness attribution
in patients with somatoform disorders were funded by a
grant from the Sino-German Center of Research Promo-
tion in Beijing. A working group of three native Chinese
speakers who resided in Germany and were fluent in writ-
ten and spoken English and German (one psychiatrist, one
psychologist, and one educator) was established to revise
the Chinese version of the PHQ-15. One translator regu-
larly participated in project meetings. Translations were
discussed during the project meetings [22, 23].
We used the Chinese version translated from English to
Mandarin by colleagues from Shanghai Mental Center [19].
Because “stomach pain” (胃痛) in item 1 was narrowly
translated to mean “gastric pain” in the mainland Chinese
version, we changed this to “stomach and abdominal pain”
(胃痛或肚痛), in accordance with the suggestions of Lee et
al. [18]. In item 8, “fainting spells” was translated to “occa-
sional fainting” (偶尔昏晕过去) in the Shanghai version,
but we preferred the Hong Kong wording of “brief fainting”
[短時間暈倒 (Cantonese),短时间晕倒 (Mandarin)]. Please
see Additional file 1.
Other than these slight changes, back-translation of
the Chinese PHQ-15 showed perfect concordance with
the English language version of the PHQ-15.
The Mandarin version of the PHQ-15 used in this
study can be provided upon request to the correspond-
ing author.
Depression scale (PHQ-9)
The Patient Health Questionnaire-9 (PHQ-9) assesses
each of the nine DSM-IV depression criteria on a scale of
“0” (not at all) to “3” (nearly every day) [24]. The PHQ-9
demonstrated acceptable psychometric properties for the
screening of patients with late-life depression in Chinese
primary care settings, as this questionnaire showed a sen-
sitivity of 0.86 and a specificity of 0.77 [25].
General Anxiety Disorder (GAD-7)
A seven-item anxiety scale (GAD-7) was used to assess the
severity of generalized anxiety [26]. In a Chinese general
hospital population, this instrument showed good reliabil-
ity and good criterion, construct, factorial, and procedural
validity [27].
Statistical analyses
Using IBM SPSS (23.0), STATA 14 and MPlus 7.3 soft-
ware, a single sample was analyzed. For descriptive ana-
lyses of the quantitative variables, mean, standard
deviation and range were calculated, and for analyses of
the qualitative variables, frequencies and percentages
were used. The distribution of the total scores obtained
using Chinese version of the PHQ-15 was studied, and
the percentage of patients with each of the possible total
scores was calculated.
Three types of analyses were performed to evaluate
validity. First, to examine the discriminant validity of the
PHQ-15, we investigated the correlations of the PHQ-15
scores with sociodemographic data and the PHQ-9 and
GAD-7 scale scores. Based on the results from previous
studies of the PHQ-15, we expected that women would
have higher somatic symptom severity (SSS) scores than
men and that the SSS scores would increase with in-
creasing age and decreasing education level [19]. Second,
reliability was analyzed in terms of internal consistency
using Cronbach’s alpha coefficient for the total scale
score. Exploratory factor analysis was performed to re-
veal the structure of the internal consistency of the
PHQ-15. Finally, IRT analysis was performed to assess
the thresholds of the items because each item had only
three answer options and could only be interpreted as
rank data.
Statistical analyses were conducted using an alpha
level of 1 % to avoid alpha inflation resulting from mul-
tiple tests.
Results
Description of the sample
Of the 1662 inpatients approached in the 10 depart-
ments, 151 patients were excluded based on the exclu-
sion criteria, and 149 patients refused to participate in
the study. The main reasons that patients gave for their
non-participation were lack of time (n = 27) or interest
(n = 60). The final sample consisted of 1362 subjects,
corresponding to an overall response rate of 90.1 %. Pa-
tients for whom more than 15 % of the data were miss-
ing were excluded. Therefore, 1329 eligible patients were
included in our study.
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The mean total score on the PHQ-15 was 6.79, with a
standard deviation of 4.94 (minimum= 0; maximum= 28).
We divided the PHQ-15 data from the sample into two
groups: the somatoform symptom (SOM) - group (PHQ-
15 score <10, n = 960, mean = 4.34, SD = 2.80) and the
SOM+ group (PHQ-15 score ≥ 10, n = 369, mean = 13.18,
SD = 3.28).
The PHQ-15 score moderately correlated with the
PHQ-9 score (r = 0.565) and the GAD-7 score (r = 0.512).
The Spearman rank correlation coefficients of the PHQ-
15 score with income (r = −0.069) and education levels
(r = −0.075) were near zero.
The sociodemographic data of the sample are presented
in Table 1. Based on an alpha level of 0.1, there were no
significant differences in sociodemographic characteristics
between the SOM- and SOM+ groups. The distributions
of education level and income were comparable to the
distributions observed in other studies performed at the
general hospitals in China [28–30].
The clinical data are presented in Table 2.
A comparison of all departments showed no significant
difference in the mean PHQ-15 score between the SOM-
and SOM+ groups considering an alpha level of 1 % (F
(9.1319) = 1.904, p = 0.048, partial Eta2 = 0.013). Significant
differences (based on MANOVA) in the mean PHQ-9 and
GAD-7 scale scores between the SOM- and SOM+ groups
were found.
Item and scale characteristics
The distributions of the items displayed extreme floor ef-
fects (see Table 3); in particular, item 4 showed a fre-
quency of 91.1 % for the null, compared to 7.4 % for item
one and 1.4 % for item two. Other items, such as items 8
and 11, displayed comparable floor effects. Item 4 showed







t/Chi2 (df ) p
Age
Mean (SD) 53.76 (16.21) 53.56 (16.02) 54.26 (16.25) −0.700 (1320) 0.484
Gender
Male 58.1 % 60.0 % 53.0 % 5.370 (1) 0.020
Female 41.9 % 40.0 % 47.0 %
Marital status
Unmarried 9.1 % 9.6 % 7.9 % 2.233 (1) 0.525
Married 87.8 % 87.8 % 88.3 %
Divorced 1.1 % 0.9 % 1.6 %
Widowed 1.9 % 1.8 % 2.2 %
Race
Han 95.5 % 4.2 % 5.2 % 0.603 (1) 0.437
Others 4.5 % 95.8 % 94.8 %
Education level
Elementary school 2.1 % 2.0 % 2.5 % 14.958 (5) 0.011
Junior high school 16.4 % 14.3 % 21.9 %
High school or secondary technical school 26.6 % 26.3 % 27.7 %
College 23.8 % 24.9 % 20.8 %
Undergraduate 17.5 % 17.9 % 16.4 %
Graduate and above 13.6 % 14.6 % 10.7 %
Income
5000 yuan and below 14.1 % 12.8 % 17.5 % 14.717 (5) 0.012
5000–9999 yuan 13.2 % 12.0 % 16.1 %
10,000–29,999 yuan 16.2 % 15.5 % 18.0 %
30,000–49,999 yuan 21.1 % 22.0 % 18.9 %
50,000–99,999 yuan 20.8 % 22.6 % 16.3 %
100,000 yuan and above 14.6 % 15.1 % 13.2 %
All percentages correspond to the n shown at the top of the given column
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a very small variance of 0.35. Other items displayed greater
variances, but none of the items displayed an ideal diffi-
culty of approximately 1 on a scale from 0 to 2. An ideal
difficulty of 1 would be valuable for improving the reliabil-
ity of the questionnaire because this is a requirement for
variance and for a large Cronbach’s alpha.
The PHQ-15 displayed a Cronbach’s alpha of 0.833.
Excluding item 4 slightly increased Cronbach’s alpha to
0.837. The item-to-item correlations were in the range
of 0.32 to 0.56. The item-to-item correlations with item
4 were less than 0.15, and the item-to-item correlations
of 6 items exceeded 0.50.
The deduced determination coefficients showed a
common variance with the PHQ-15 score of 31.9 % for
the PHQ-9 score and 26.2 % for the GAD-7 scale score.
The discriminant validity of the PHQ-15 is therefore ac-
ceptable because the PHQ-15 measures different con-
structs than the PHQ-9 or the GAD-7 scale in this
sample. Cronbach’s alpha was 0.908 for the PHQ-9 and
0.815 for the GAD-7 scale.
Factorial validity
For internal consistency, we performed exploratory factor
analysis on the categorical data using MPlus software (see
Table 4). All subjects were included in this analysis. By
adopting the Kaiser criterion (Eigenvalue >1), three factors
were extracted; these factors accounted for 55.97 % of the
total variance. The Eigenvalues of the three factors were
as follows: factor 1 = 6.026, factor 2 = 1.279 and factor
3 = 1.091. Based on this factor structure, the items load-
ing the 3 factors may be termed “cardiopulmonary”,
“gastrointestinal” and “pain”. Thirteen items of the PHQ-
15 loaded on only one of the factors; in contrast, items 1
and 2 cross-loaded on two of the factors. The Chi-Square
Test of Model Fit showed that the sample size was accept-
able (Chi2 = 371.064, df = 63, p < 0.0001). The root mean
square error of approximation (RMSEA) of 0.061 was ac-
ceptable (90 % C.I.: 0.055 - 0.067). The Comparative Fit
Index (CFI) was adequate (0.961), and the Tucker-Lewis
Index (TLI) was acceptable (0.935). The standardized root
mean square residual (SRMR) was approximately 0.048.
Table 2 Clinical measures
N = 1329 SOM- group (PHQ-15
score <10) N = 960
SOM+ group (PHQ-15
score ≥10) N = 369
Categorical variables n (%) n (%) Chi2 (df )/p
Smoking
Never 755 (57.5 %) 534 (56.3 %) 221 (60.5 %) 4.234 (2) 0.120
Once, has quit smoking 465 (35.4 %) 339 (35.8 %) 126 (34.5 %)
Still smoking 93 (7.1 %) 75 (7.9 %) 18 (4.9 %)
Use of alcohol
Never drink 709 (54.3 %) 502 (53.2 %) 207 (57.3 %) 4.352 (3) 0.226
Social drinking 358 (27.4 %) 274 (29.0 %) 84 (23.3 %)
Prior daily drinking (now stopped) 211 (16.2 %) 149 (15.8 %) 62 (17.2 %)
Drink almost every day (more than 3 days/week) 27 (2.1 %) 19 (2.0 %) 8 (2.2 %)
Department
Respiratory Medicine 142 (10.7 %) 97 (10.1 %) 45 (12.2 %) 19.083 (9) 0.024
Internal Cardiology 153 (11.5 %) 107 (11.1 %) 46 (12.5 %)
Rheumatology 75 (5.6 %) 42 (4.4 %) 33 (8.9 %)
Pain Management 30 (2.3 %) 24 (2.5 %) 6 (1.6 %)
Rehabilitation 119 (9.0 %) 84 (8.8 %) 35 (9.5 %)
Oncology 527 (39.7 %) 399 (41.6 %) 128 (34.7 %)
Geriatrics and Gerontology 115 (8.7 %) 79 (8.2 %) 36 (9.8 %)
Thyroid and Breast Surgery 46 (3.5 %) 38 (4.0 %) 8 (2.2 %)
Hepatic Surgery 61 (4.6 %) 44 (4.6 %) 17(4.6 %)
General Practice 61 (4.6 %) 46 (4.8 %) 15 (4.1 %)
Continuous variables MANOVA M (SD) M (SD) M (SD) F (df1,df2) p (partial Eta2)
PHQ-9 score 7.59 (5.05) 6.16 (4.38) 11.31 (4.79) 349.245 (1,1327) <0.001 (0.208)
GAD-7 score 5.12 (4.75) 3.86 (3.85) 8.42 (5.26) 301.935 (1,1327) <0.001(0.185)
All % are column percentages
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The geomin-rotated factors showed correlations between
0.418 and 0.531.
Ten out of the fifteen variables in this model had signifi-
cant double- or, in some cases, triple-loadings. Some of
these double-loadings had nearly the same values. However,
a one-factor model displayed a worse fit (Chi2 = 928.208,
df = 90, p < 0.0001). The RMSEA of 0.084 was not ac-
ceptable (90 % C.I.: 0.079 - 0.089). The CFI was mar-
ginal (0.894), and the TLI was marginal or unacceptable
(0.876). The SRMR was approximately 0.077. Because the
three factors moderately correlated, the one-factor-model
displayed a poor fit, and because the authors of the ques-
tionnaire used the sum of all items as an outcome, we con-
ducted second-order factor analysis considering these three
factors and a second-order factor. The Chi-Square Test of
Model Fit considered the large sample size to be acceptable
(Chi2 = 451.988, df = 85, p < 0.0001. The RMSEA of 0.057
was acceptable (90 % C.I.: 0.052 - 0.062). The CFI was
adequate (0.954), and the TLI was acceptable (0.943). The
weighted root mean square residual (WRMR) was approxi-
mately 1.554. For this model, double-loading for items 1
and 2 was supposed. The R2 of the three factors was high
(Factor 1 = 0.733, Factor 2 = 0.622, and Factor 3 = 0.684).
IRT analysis
IRT analysis of the partial credit model showed that all
of the items suited the model. The problematic item 4
displayed two thresholds in the appropriate order, but
these thresholds did not markedly differ (2.498 vs 2.583).
All of the other items showed greater differences in their
thresholds and showed adequate results based on IRT
analysis (see Table 5).
In three further IRT analyses of the partial credit
model, all of the items within the three factors showed
good fitness in the models. Although item 4 remained
problematic, the three-factor solution was acceptable
(see Table 6).
Discussion
The present study evaluated the Chinese version of the
PHQ-15 in a large tertiary hospital inpatient setting in
Chengdu. The results revealed satisfactory reliability
Table 4 Geomin-rated factor loadings
Item Factor 1 Factor 2 Factor 3 Residual variances
1 0.406a −0.058 0.435a 0.520
2 0.392a 0.043 0.331a 0.581
3 0.363a −0.014 0.251a 0.726
4 0.359a −0.044 −0.002 0.886
5 0.838a −0.092 0.006 0.367
6 0.507a 0.201a 0.082 0.534
7 0.653a 0.017 0.106a 0.483
8 0.588a 0.218a −0.130a 0.550
9 0.176a 0.724a −0.001 0.309
10 0.005 0.853a 0.053 0.228
11 0.485a 0.089 −0.018 0.721
12 0.091 0.041 0.566a 0.597
13 0.179a −0.001 0.646a 0.441
14 −0.021 0.272a 0.658a 0.362
15 0.079 0.245a 0.457a 0.576
asignificant at the 5 % level
Table 3 Descriptive statistics for the PHQ-15
Item Mean score (SD) Frequency of score 0 (%) Frequency of score 1 (%) Frequency of score 2 (%) Part-hole corrected
item-to-scale correlation
1 0.37 (0.59) 917 (69.0 %) 336 (25.3 %) 76 (5.7 %) 0.489
2 0.53 (0.64) 733 (55.2 %) 488 (36.7 %) 108 (8.1 %) 0.505
3 0.60 (0.70) 703 (52.9 %) 458 (34.5 %) 168 (12.6 %) 0.396
4 0.10 (0.35) 1211 (91.1 %) 99 (7.4 %) 19 (1.4 %) 0.146
5 0.39 (0.57) 869 (65.4 %9 400 (30.1 %) 60 (4.5 %) 0.488
6 0.41 (0.59) 850 (64.0 %) 409 (30.8 %) 70 (5.3 %) 0.501
7 0.48 (0.59) 758 (57.0 %) 509 (38.3 %) 62 (4.7 %) 0.508
8 0.20 (0.48) 1109 (83.4 %) 175 (13.2 %) 45 (3.4 %) 0.380
9 0.44 (0.59) 815 (61.3 %) 444 (33.4 %) 70 (5.3 %) 0.526
10 0.40 (0.62) 891 (67.0 %) 342(25.7 %) 96 (7.2 %) 0.487
11 0.21 (0.48) 1099 (82.7 %) 184 (13.8 %) 46 (3.5 %) 0.318
12 0.60 (0.67) 672 (50.6 %) 522 (39.3 %) 135 (10.2 %) 0.435
13 0.58 (0.65) 685 (51.5 %) 522 (39.3 %) 122 (9.2 %) 0.517
14 0.77 (0.66) 479 (36.0 %) 675 (50.8 %) 175 (13.2 %) 0.556
15 0.72 (0.72) 578 (43.5 %) 542 (40.8 %) 209 (15.7 %) 0.489
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(Cronbach’s alpha = 0.83) of this scale and good evi-
dence of its validity. Cronbach’s alpha in this study was
higher than that in Western and Chinese studies (be-
tween 0.78 and 0.82).
The correlations of the PHQ-15 scores with the PHQ-
9 depression scale and the GAD-7 anxiety scale scores
were similar to the correlations between these instru-
ments in other studies; this evidence suggests that the
PHQ-15 has discriminant validity [31].
The correlations of the PHQ-15 score with the PHQ-9
and GAD-7 scale scores were not sufficiently high to
completely attribute the PHQ-15 results to coexisting
depressive and anxiety symptoms. Aside from medical
comorbidities, functional or bodily distress symptoms
were observed as factors (discriminant validity).
In a factor analysis of a former version of the PHQ-15
in a USA clinical study, three factors were identified: car-
diopulmonary, gastrointestinal, and general pain/fatigue
(explanation of the total variance: 46 %) [32]. A study from
Hong Kong [18] determined four clinically meaningful
factors that explained 49.7 % of the total variance: “cardio-
pulmonary,” “gastrointestinal,” “pain” and “neurological”.
Table 5 Thresholds for the PHQ-15 based on IRT analysis
Diff. Coef. Std. Err. z P > z [95 % Conf. Interval]
Item 1 1 vs 0 0.994 0.069 14.44 <0.001 0.859 1.129
2 vs 1 2.132 0.124 17.13 <0.001 1.888 2.376
Item 2 1 vs 0 0.355 0.061 5.76 <0.001 0.235 0.476
2 vs 1 2.024 0.108 18.75 <0.001 1.812 2.235
Item 3 1 vs 0 0.326 0.063 5.19 <0.001 0.203 0.448
2 vs 1 1.532 0.091 16.83 <0.001 1.354 1.710
Item 4 1 vs 0 2.498 0.114 21.89 <0.001 2.274 2.721
2 vs 1 2.583 0.228 11.34 <0.001 2.136 3.029
Item 5 1 vs 0 0.780 0.065 12.00 <0.001 0.652 0.907
2 vs 1 2.472 0.137 18.10 <0.001 2.204 2.740
Item 6 1 vs 0 0.725 0.064 11.24 <0.001 0.598 0.851
2 vs 1 2.338 0.128 18.22 <0.001 2.087 2.590
Item 7 1 vs 0 0.387 0.061 6.35 <0.001 0.268 0.506
2 vs 1 2.587 0.135 19.17 <0.001 2.323 2.852
Item 8 1 vs 0 1.849 0.090 20.57 <0.001 1.673 2.025
2 vs 1 2.187 0.157 13.96 <0.001 1.880 2.494
Item 9 1 vs 0 0.597 0.063 9.49 <0.001 0.474 0.720
2 vs 1 2.389 0.128 18.62 <0.001 2.138 2.641
Item 10 1 vs 0 0.928 0.068 13.60 <0.001 0.794 1.062
2 vs 1 1.914 0.114 16.85 <0.001 1.691 2.137
Item 11 1 vs 0 1.792 0.088 20.35 <0.001 1.619 1.964
2 vs 1 2.202 0.155 14.21 <0.001 1.898 2.505
Item 12 1 vs 0 0.172 0.061 2.81 0.005 .0519 0.292
2 vs 1 1.840 0.099 18.61 <0.001 1.646 2.033
Item 13 1 vs 0 0.203 0.061 3.32 0.001 0.083 0.323
2 vs 1 1.942 0.103 18.88 <0.001 1.741 2.144
Item 14 1 vs 0 −0.485 0.067 −7.60 <0.001 −0.610 −0.360
2 vs 1 1.719 0.090 19.23 <0.001 1.544 1.894
Item 15 1 vs 0 −0.843 0.062 −1.35 0.177 −0.207 0.038
2 vs 1 1.403 0.084 16.79 <0.001 1.239 1.567
Partial credit model, number of observations = 1329
Log likelihood = −14252.727
AIC = 28567.45
BIC = 28728.41
Table 6 Thresholds for the three possible factors of the PHQ-15
based on IRT analysis
Diff. Coef. Std. Err. z P > z [95 % Conf. Interval]
Factor 1
Item 2 1 vs 0 0.351 0.064 5.49 <0.001 0.226 0.477
2 vs 1 2.094 0.114 18.31 <0.001 1.870 2.318
Item 3 1 vs 0 0.320 0.065 4.92 <0.001 0.193 0.448
2 vs 1 1.577 0.095 16.52 <0.001 1.390 1.764
Item 4 1 vs 0 2.590 0.126 20.50 <0.001 2.342 2.838
2 vs 1 2.685 0.237 11.32 <0.001 2.220 3.150
Item 5 1 vs 0 0.792 0.068 11.58 <0.001 0.658 0.926
2 vs 1 2.567 0.145 17.71 <0.001 2.282 2.851
Item 6 1 vs 0 0.734 0.068 10.85 <0.001 0.602 0.867
2 vs 1 2.427 0.136 17.83 <0.001 2.160 2.693
Item 7 1 vs 0 0.385 0.064 6.09 <0.001 0.261 0.509
2 vs 1 2.684 0.144 18.61 <0.001 2.401 2.966
Item 8 1 vs 0 1.910 0.099 19.38 <0.001 1.716 2.103
2 vs 1 2.277 0.164 13.90 <0.001 1.956 2.598
Item 11 1 vs 0 1.849 0.096 19.19 <0.001 1.661 2.038
2 vs 1 2.292 0.162 14.14 <0.001 1.975 2.610
Factor 2
Item 9 1 vs 0 0.366 0.040 9.16 <0.001 0.288 0.445
2 vs 1 1.872 0.080 23.43 <0.001 1.715 2.029
Item 10 1 vs 0 0.558 0.042 13.18 <0.001 0.475 0.641
2 vs 1 1.641 0.070 23.30 <0.001 1.503 1.779
Factor 3
Item 1 1 vs 0 0.867 0.063 13.80 <0.001 0.745 0.992
2 vs 1 2.052 0.112 18.37 <0.001 1.833 2.271
Item 12 1 vs 0 0.122 0.055 2.21 0.027 0.014 0.230
2 vs 1 1.737 0.089 19.42 <0.001 1.561 1.912
Item 13 1 vs 0 0.152 0.055 2.76 0.006 0.044 0.260
2 vs 1 1.831 0.093 19.67 <0.001 1.649 2.014
Item 14 1 vs 0 −0.469 0.057 −8.18 <0.001 −0.581 −0.357
2 vs 1 1.598 0.081 19.64 <0.001 1.439 1.758
Item 15 1 vs 0 −0.118 0.056 −2.10 0.035 −0.228 0.008
2 vs 1 1.329 0.075 17.62 <0.001 1.181 1.477
Partial credit model, number of observations = 1329
Factor 1: Log likelihood = −7025.6965; AIC = 14085.390; BIC = 14173.660
Factor 2: Log likelihood = −1942.3235; AIC = 3894.647; BIC = 3920.608
Factor 3: Log likelihood = −5613.5482; AIC = 11249.100; BIC = 11306.210
Zhang et al. BMC Psychiatry  (2016) 16:89 Page 7 of 9
A study from Shanghai [19] identified three factors:
“general discomfort,” “gastro-intestinal discomfort” and
“cardiothoracic discomfort” (explanation of the total
variance: 54 %). Based on factorial analysis in our study,
we identified three factors, referred to as “cardiopulmo-
nary” “gastrointestinal” and “pain/neurological,” which ex-
plained 56 % of the total variance. A second-order factor
analysis including these three factors produced an accept-
able model. Because of substantial double-factor loadings,
a unidimensional model is also discussed.
Item 4 (menstrual problems), item 8 (sexual problems)
and item 11 (fainting spells) displayed extreme floor ef-
fects. These floor effects were also found in previous
Chinese and Western studies [18, 19, 21, 29, 33, 34]. Add-
itionally, item 4 displayed a very small variance of 0.35
and showed very small differences in its thresholds based
on IRT analysis.
Because of their limited associations with other items,
rare symptom prevalence, and limited associations with
measures of functioning, quality of life, and health ser-
vice use, these three items were not included in a new
questionnaire, termed “The Somatic Symptom Scale-8”
(SSS-8) [35].
Strengths and limitations
This is the first validation study of the PHQ-15 in a large
sample of patients at a major Chinese tertiary hospital
that has a full complement of services for a broad range
of medical conditions.
The sample included the most important depart-
ments of a general hospital. The patients were repre-
sentative of general hospital inpatients with respect to
sex, marital status, education level and income level.
The overall response rate was very high (90.1 %). The
validation process included IRT analysis, which is a new
analysis of the PHQ-15.
However, there were some limitations of our study.
(1) We did not perform a structured clinical interview;
therefore, the sensitivity and specificity of the PHQ-15
for assessing somatoform disorders could not be estab-
lished. However, the PHQ-15 is best characterized as a
measure of somatic symptom severity rather than a
diagnostic instrument for somatoform disorders [5]. It
would be important to diagnose patients with a new
classification system of somatic symptom disorders in
China. (2) The study was cross-sectional. Longitudinal
studies are needed to determine the test-retest reliabil-
ity of the PHQ-15 and its responsiveness to treatment.
(3) There was no assessment of functional status or
health-related quality of life. (4) There was no systematic
assessment of medical conditions or independent measure
of healthcare utilization. (5) Indigenous and common ex-
pressions of somatic distress among Chinese patients are
not captured by the PHQ-15. (6) A multi-center study
would be an optimal approach.
Conclusions
The PHQ-15 displayed adequate reliability and good evi-
dence of validity for detecting patients with severe somatic
symptoms in a Chinese hospital. Several of the current
findings were consistent with previous research regard-
ing the PHQ-15. To improve the diagnostic quality of
the PHQ-15, items 4, 8 and 11 can be omitted.
Future research should examine whether differences in
factorial structure and the cross-loading of items across
populations are related to sampling, methodological fac-
tors and/or cultural differences in experiences with som-
atic disorders.
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